Safety: No therapy-related adverse effects were reported
High-sensitivity C-reactive protein, a measure of inflammation in your body, goes down with retatrutide
CJC-1131, a new chemical-modified GLP-1 agonist, was effective in resisting DPP-4 degradation
Publisher Responsibility Disclaimer: This content was produced by an independent publisher in connection with a marketing arrangement
Learn More Advanced dual-action GLP-1 medication, clinically shown to achieve weight loss of 15-20%, offers enhanced comprehensive weight management benefits
Many patients starting GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) wonder about this symptom